GXI — Gerresheimer AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapValue Trap

Annual income statement for Gerresheimer AG, fiscal year end - November 30th, EUR millions except per share, conversion factor applied.

	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,419	1,498	1,817	1,990	2,036
Cost of Revenue
Gross Profit	438	442	547	597	608
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,262	1,351	1,648	1,777	1,838
Operating Profit	156	147	169	213	197
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	135	128	141	167	147
Provision for Income Taxes
Net Income After Taxes	89.9	87.2	102	120	112
Minority Interest
Net Income Before Extraordinary Items
Net Income	88.6	83.8	96.1	116	110
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	88.6	83.8	96.1	116	110
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.05	2.87	3.47	3.75	3.45
Dividends per Share